Company Search:
Advanced Search
Sponsored Links
Mirati Therapeutics Inc Company Snapshot
Mirati Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mirati Therapeutics Inc with three other companies in this sector in CANADA : Liminal BioSciences Inc (2019 sales of 4.90 million Canadian Dollars [US$3.72 million] of which 97% was Plasma derived therapeutics), Pond Technologies Holdings Inc (6.14 million Canadian Dollars [US$4.65 million] of which 58% was Nutraceutical Products), and VBI Vaccines Inc (2.94 million Canadian Dollars [US$2.23 million] of which 76% was R&D Service revenue).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mirati Therapeutics Inc
  Stock Performance Chart for Mirati Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 236.96
(Figures in Canadian Dollars)
1 Week -9.5%   13 Weeks 5.8%  
4 Weeks 51.5%   52 Weeks 124.4%  
Mirati Therapeutics Inc Key Data:
  Ticker: MRTX Country: United States
  Exchanges: TOR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 4,412,839
(Year Ending Jan 2020).
Employees: 111
  Currency: Canadian Dollars Market Cap: 10,540,661,151
  Fiscal Yr Ends: December Shares Outstanding: 44,482,308
  Share Type: COMMON Closely Held Shares: 3,694,389
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.